drugset / Trial / NCT04528927
Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia
Phase 3
Withdrawn
Abderrahmane Mami Hospital
Datametrix · collabEshmoun Clinical Research Center · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Evaluation of the efficacy and safety of Treatments for Patients Hospitalized for COVID-19 Infection without signs of acute respiratory failure, in Tunisia Multicentric Randomized Comparative Study
Timeline
- Start
- 2020-05-15
- Primary completion
- 2020-07-15
- Completion
- 2020-07-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azithromycin | Small molecule | 250 mg | — |
| Subject | Doxycycline | Small molecule | 200 mg | — |
| Subject | Hydroxychloroquine | Small molecule | 200 mg | — |